Indian Government To Negotiate Prices Of Imported Patented Drugs With MNCs
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Multinational pharma companies may soon have to voluntarily price their patented drugs in India at levels that are the lowest in the world. In addition, they may have to provide a percentage waiver on the maximum retail price of the drugs that are procured in bulk for the Indian public health system